Dashboard
Manage Tickers

MRKRMarker Therapeutics, Inc.

Nasdaq markertherapeutics.com


$ 4.30 $ -0.08 (-1.72 %)    

Friday, 26-Apr-2024 14:54:14 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 432.78 $ -0.37 (-0.09 %)
DIA $ 382.27 $ 1.39 (0.36 %)
SPY $ 508.26 $ 4.77 (0.95 %)
TLT $ 88.26 $ 0.46 (0.52 %)
GLD $ 216.60 $ 0.70 (0.32 %)
$ 4.29
$ 4.30
$ 0.00 x 0
$ 0.00 x 0
$ 4.30 - $ 4.30
$ 0.76 - $ 9.68
12,576
na
37.79M
$ 1.02
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 03-25-2024 12-31-2023 10-K
2 11-09-2023 09-30-2023 10-Q
3 08-14-2023 06-30-2023 10-Q
4 05-15-2023 03-31-2023 10-Q
5 03-22-2023 12-31-2022 10-K
6 11-10-2022 09-30-2022 10-Q
7 08-11-2022 06-30-2022 10-Q
8 05-12-2022 03-31-2022 10-Q
9 03-17-2022 12-31-2021 10-K
10 11-10-2021 09-30-2021 10-Q
11 08-10-2021 06-30-2021 10-Q
12 05-12-2021 03-31-2021 10-Q
13 03-09-2021 12-31-2020 10-K
14 11-09-2020 09-30-2020 10-Q
15 08-10-2020 06-30-2020 10-Q
16 05-11-2020 03-31-2020 10-Q
17 03-12-2020 12-31-2019 10-K
18 11-12-2019 09-30-2019 10-Q
19 08-09-2019 06-30-2019 10-Q
20 05-10-2019 03-31-2019 10-Q
21 03-15-2019 12-31-2018 10-K
22 11-13-2018 09-30-2018 10-Q
23 08-09-2018 06-30-2018 10-Q
24 05-15-2018 03-31-2018 10-Q
25 03-23-2018 12-31-2017 10-K
26 11-14-2017 09-30-2017 10-Q
27 08-07-2017 06-30-2017 10-Q
28 05-05-2017 03-31-2017 10-Q
29 03-14-2017 12-31-2016 10-K
30 11-04-2016 09-30-2016 10-Q
31 08-15-2016 06-30-2016 10-Q
32 05-16-2016 03-31-2016 10-Q
33 04-14-2016 12-31-2015 10-K
34 11-16-2015 10-30-2015 10-Q
35 08-14-2015 06-30-2015 10-Q
36 05-15-2015 03-31-2015 10-Q
37 04-15-2015 12-31-2014 10-K
38 11-19-2014 09-30-2014 10-Q
39 08-18-2014 06-30-2014 10-Q
40 05-20-2014 03-31-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

marker-therapeutics-reports-2023-net-loss-of-82m-vs-net-loss-of-299m-last-year
Marker Therapeutics Reports 2023 Net Loss ...
03/25/2024 21:56:13

At December 31, 2023, Marker had cash and cash equivalents of $15.1 million. The Company believes that its existing cash and ca...

marker-therapeutics-receives-approval-from-united-states-adopted-name-council-and-international-nonproprietary-names-expert-committee-for-neldaleucel-as-nonproprietary-name-for-mt-601
Marker Therapeutics Receives Approval from...
01/22/2024 12:46:16

cancer-cell-therapy-focused-marker-therapeutics-announces-pipeline-prioritization
Cancer Cell Therapy Focused Marker Therape...
01/08/2024 12:31:07

Marker Therapeutics Inc (NASDAQ: MRKR) announced it is restructuring its clinical programs and strategic prioritization of its ...

marker-therapeutics-says-multitaa-specific-t-cell-therapies-demonstrate-clinical-safety-and-positive-clinical-data-across-multiple-indications
Marker Therapeutics Says 'MultiTAA-specifi...
01/08/2024 12:30:11

marker-therapeutics-says-strategic-prioritization-of-clinical-programs-with-focus-on-mt-601-in-patients-with-lymphoma
Marker Therapeutics Says 'Strategic priori...
01/08/2024 12:30:04

marker-therapeutics-announces-clinical-program-updates-and-pipeline-prioritization
Marker Therapeutics Announces Clinical Pro...
01/08/2024 12:29:56

12-health-care-stocks-moving-in-fridays-after-market-session
12 Health Care Stocks Moving In Friday's A...
12/29/2023 21:31:10

12-health-care-stocks-moving-in-mondays-intraday-session
12 Health Care Stocks Moving In Monday's I...
12/11/2023 17:30:56

marker-therapeutics-announces-sustained-complete-response-in-first-lymphoma-patient-treated-with-mt-601-following-car-t-relapse
Marker Therapeutics Announces Sustained Co...
12/11/2023 12:04:24

Marker Therapeutics, Inc. (NASDAQ:MRKR), a clinical-stage immuno-oncology company focusing on developing next-generation T cell...

marker-therapeutics-q3-eps-034-up-from-080-yoy-sales-25761k-down-from-395m-yoy
Marker Therapeutics Q3 EPS $(0.34) Up From...
11/10/2023 00:03:53

Marker Therapeutics (NASDAQ:MRKR) reported quarterly losses of $(0.34) per share. This is a 57.5 percent increase over losses o...

why-is-blood-cancer-focused-marker-therapeutics-stock-trading-higher-today
Why Is Blood Cancer Focused Marker Therape...
09/11/2023 17:46:27

Marker Therapeutics Inc (NASDAQ: MRKR) released the preliminary results of the first participant treated with MT-601, its multi...

why-avantax-shares-are-trading-higher-by-over-27-here-are-other-stocks-moving-in-mondays-mid-day-session
Why Avantax Shares Are Trading Higher By O...
09/11/2023 17:38:46

Gainers Crinetics Pharmaceuticals, Inc. (NASDAQ: CRNX) jumped 76% to $28.13 after the company's once-daily oral paltuso...

marker-therapeutics-announced-the-preliminary-results-of-the-first-participant-treated-with-mt-601-its-multi-tumor-associated-antigen-specific-t-cell-product-targeting-6-taas-in-the-phase-1-multicenter-apollo-trial
Marker Therapeutics Announced The Prelimin...
09/11/2023 11:04:51

marker-therapeutics-q2-eps-029-up-from-110-yoy-sales-76266k-down-from-79051k-yoy
Marker Therapeutics Q2 EPS $0.29 Up From $...
08/14/2023 20:57:04

Marker Therapeutics (NASDAQ:MRKR) reported quarterly earnings of $0.29 per share. This is a 126.36 percent increase over losses...

marker-therapeutics-announced-non-clinical-data-of-its-lead-multi-tumor-associated-antigen-multitaa-specific-t-cell-product-candidate-mt-401-in-an-off-the-shelf-setting-and-provided-an-update-on-clinical-readiness-for-the-off-the-shelf-program
Marker Therapeutics Announced Non-clinical...
08/07/2023 11:36:47

why-apellis-pharmaceuticals--shares-are-trading-lower-by-around-19-here-are-other-stocks-moving-in-mondays-session
Why Apellis Pharmaceuticals Shares Are Tr...
07/31/2023 19:30:12

Gainers Yellow Corporation (NASDAQ: YELL) shares jumped 106% to $1.46. The trucking company ceased operations on Sunday, acc...

12-health-care-stocks-moving-in-mondays-intraday-session
12 Health Care Stocks Moving In Monday's I...
07/31/2023 17:31:28

12-health-care-stocks-moving-in-fridays-intraday-session
12 Health Care Stocks Moving In Friday's I...
07/28/2023 17:31:12

why-ryanair-holdings-shares-are-trading-lower-by-8-here-are-other-stocks-moving-in-mondays-mid-day-session
Why Ryanair Holdings Shares Are Trading Lo...
07/24/2023 18:54:54

Gainers Tupperware Brands Corporation (NYSE: TUP) shares jumped 59% to $1.43 on above-average volume amid retail investor i...

12-health-care-stocks-moving-in-mondays-intraday-session
12 Health Care Stocks Moving In Monday's I...
07/24/2023 17:31:03

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION